Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00414921Phase 2Completed
A Phase 2 trial of clonidine, methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of Cincinnati. Started Sep 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00414921.